Fluorescence biomarkers of malignant melanoma detectable in urine

Malignant melanoma (MM) is a cancerous transformation of melanocytes. It is a disease with the worst response to therapy and, compared to other malignancies, presents much earlier with metastases. MM still belongs to relatively late-detected malignant diseases. Even so, the MM mortality rate is up t...

Full description

Bibliographic Details
Main Authors: Špaková Ivana, Dubayová Katarína, Nagyová Vladimíra, Mareková Mária
Format: Article
Language:English
Published: De Gruyter 2020-08-01
Series:Open Chemistry
Subjects:
Online Access:https://doi.org/10.1515/chem-2020-0143
_version_ 1819291511818289152
author Špaková Ivana
Dubayová Katarína
Nagyová Vladimíra
Mareková Mária
author_facet Špaková Ivana
Dubayová Katarína
Nagyová Vladimíra
Mareková Mária
author_sort Špaková Ivana
collection DOAJ
description Malignant melanoma (MM) is a cancerous transformation of melanocytes. It is a disease with the worst response to therapy and, compared to other malignancies, presents much earlier with metastases. MM still belongs to relatively late-detected malignant diseases. Even so, the MM mortality rate is up to 96% for a relatively small incidence (5%). The gold standard for MM diagnosis is a histopathological examination that requires invasive surgery. An invasive sampling method of a biological material can be a stressful factor for the patient, which is often the reason why patients do not seek medical assistance as soon as possible. Our goal was to find a link between metabolites in urine and the stage of MM. Two excitation peaks at 360–370 nm and 450 nm were characterised in spectra of urine samples. The emission spectra have shown one significant peak at 410–460 nm. After addition of glutathione reductase to the samples, fluorescence dropped down only in patient samples and hidden fluorophores appeared. Malignant diseases are associated with the presence of specific metabolites that can be detected fluorescently in biological material such as urine, which can be a suitable alternative for an early detection of cancer or for tracking changes during and after treatment.
first_indexed 2024-12-24T03:39:48Z
format Article
id doaj.art-41f07b5e994844fa8dd95ff36ff551c3
institution Directory Open Access Journal
issn 2391-5420
language English
last_indexed 2024-12-24T03:39:48Z
publishDate 2020-08-01
publisher De Gruyter
record_format Article
series Open Chemistry
spelling doaj.art-41f07b5e994844fa8dd95ff36ff551c32022-12-21T17:16:56ZengDe GruyterOpen Chemistry2391-54202020-08-0118189891010.1515/chem-2020-0143chem-2020-0143Fluorescence biomarkers of malignant melanoma detectable in urineŠpaková Ivana0Dubayová Katarína1Nagyová Vladimíra2Mareková Mária3Department of Medical and Clinical Biochemistry, Pavol Jozef Šafárik University in Košice, Faculty of Medicine, Trieda SNP 1, Košice, 04011, SlovakiaDepartment of Medical and Clinical Biochemistry, Pavol Jozef Šafárik University in Košice, Faculty of Medicine, Trieda SNP 1, Košice, 04011, SlovakiaDepartment of Dermatovenerology, Pavol Jozef Šafárik University in Košice, Faculty of Medicine, Košice, 04011, SlovakiaDepartment of Medical and Clinical Biochemistry, Pavol Jozef Šafárik University in Košice, Faculty of Medicine, Trieda SNP 1, Košice, 04011, SlovakiaMalignant melanoma (MM) is a cancerous transformation of melanocytes. It is a disease with the worst response to therapy and, compared to other malignancies, presents much earlier with metastases. MM still belongs to relatively late-detected malignant diseases. Even so, the MM mortality rate is up to 96% for a relatively small incidence (5%). The gold standard for MM diagnosis is a histopathological examination that requires invasive surgery. An invasive sampling method of a biological material can be a stressful factor for the patient, which is often the reason why patients do not seek medical assistance as soon as possible. Our goal was to find a link between metabolites in urine and the stage of MM. Two excitation peaks at 360–370 nm and 450 nm were characterised in spectra of urine samples. The emission spectra have shown one significant peak at 410–460 nm. After addition of glutathione reductase to the samples, fluorescence dropped down only in patient samples and hidden fluorophores appeared. Malignant diseases are associated with the presence of specific metabolites that can be detected fluorescently in biological material such as urine, which can be a suitable alternative for an early detection of cancer or for tracking changes during and after treatment.https://doi.org/10.1515/chem-2020-0143nad(p)hlipofuscinhif-1αmitf-migf1
spellingShingle Špaková Ivana
Dubayová Katarína
Nagyová Vladimíra
Mareková Mária
Fluorescence biomarkers of malignant melanoma detectable in urine
Open Chemistry
nad(p)h
lipofuscin
hif-1α
mitf-m
igf1
title Fluorescence biomarkers of malignant melanoma detectable in urine
title_full Fluorescence biomarkers of malignant melanoma detectable in urine
title_fullStr Fluorescence biomarkers of malignant melanoma detectable in urine
title_full_unstemmed Fluorescence biomarkers of malignant melanoma detectable in urine
title_short Fluorescence biomarkers of malignant melanoma detectable in urine
title_sort fluorescence biomarkers of malignant melanoma detectable in urine
topic nad(p)h
lipofuscin
hif-1α
mitf-m
igf1
url https://doi.org/10.1515/chem-2020-0143
work_keys_str_mv AT spakovaivana fluorescencebiomarkersofmalignantmelanomadetectableinurine
AT dubayovakatarina fluorescencebiomarkersofmalignantmelanomadetectableinurine
AT nagyovavladimira fluorescencebiomarkersofmalignantmelanomadetectableinurine
AT marekovamaria fluorescencebiomarkersofmalignantmelanomadetectableinurine